

Are we prescribing antibiotics wrong?

Outsourcing Clinical Trials Outside of the US

Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Two-dimensional liquid chromatography with multiple heart-cutting

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment





Latest White Papers
- Random
Featured News
Latest News
- Title
- Most Views
- Recently Added
- Ordering
- Random



CollPlant Biotechnologies , or 'CollPlant', a regenerative and aesthetics medicine company ...

BIOTRONIK Neuro will unveil new data from the BENEFIT-03 clinical study. The findings highlight the ...

Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated ...

A team of international researchers led by scientists at City of Hope, one of the largest and most ...



Latest Updates
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces the appointment of ...
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces the appointment of Abdelghani (Abdel) Omari as its first-ever Chief Financial Officer (CFO).
This milestone appointment ...
Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor ...
Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain. JOURNAVX is an effective, ...
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's Access ...
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's Access p‑Tau217/β-Amyloid 1-42 plasma ratio. This blood test is designed to aid healthcare providers identify ...
Young Pharmaceuticals, Inc., a leading provider of physician-dispensed skincare products, announces an exclusive distribution agreement with LAC2βiome S.r.l., a maker of microbial based product ...
Young Pharmaceuticals, Inc., a leading provider of physician-dispensed skincare products, announces an exclusive distribution agreement with LAC2βiome S.r.l., a maker of microbial based product solutions in Milan, Italy.
The product line offers a science-driven approach to improving skin ...
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure ...
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure system.
The new closure, V-OVS® next, will further advance a proprietary system with many years ...
Yamaha Motor Co., Ltd. (Tokyo: 7272) announced that it will exhibit the CELL HANDLER™ 2, a cell picking and imaging system, at marking the product's first overseas exhibition.
At the exhibition, ...
Yamaha Motor Co., Ltd. (Tokyo: 7272) announced that it will exhibit the CELL HANDLER™ 2, a cell picking and imaging system, at marking the product's first overseas exhibition.
At the exhibition, Yamaha Motor will showcase the CELL HANDLER™ 2 in action. Additionally, the Dutch-based ...